UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
July 28, 2004
---------------------------
(Date of Report)
ELITE PHARMACEUTICALS, INC.
-----------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 333-45241 22-3542636
------------ ------------- --------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
165 Ludlow Avenue, Northvale, New Jersey 07647
---------------------------------------------------------------
(Address of principal executive offices)
(201) 750-2646
---------------------
(Registrant's telephone number, including area code)
Item 5. OTHER EVENTS AND REGULATION FD DISCLOSURE
The Registrant issued on July 28, 2004, a press release announcing it
has amended its Certificate of Incorporation to increase its authorized shares
of capital stock from 25,000,000 shares of Common Stock, par value $0.01 per
share, to 65,000,000 shares of Common Stock, par value $0.01 per share and
5,000,000 shares of Preferred Stock, par value $0.01 per share. The amendment to
the Certificate of Incorporation was approved by the Registrant's stockholders
at its adjourned Annual Meeting of the Stockholders.
A copy of Registrant's press release is attached as Exhibit 99.1 and a
certified copy of the Certificate of Amendment of the Certificate of
Incorporation of the Registrant is filed as exhibit 3.1
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
a) Not applicable.
b) Not applicable.
c) Exhibits
3.1 Certified copy of the Certificate of Amendment of the
Certificate of Incorporation filed with the Secretary
of State of Delaware on July 26, 2004.
99.1. Press Release, dated May 14, 2004
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: July 28, 2004
ELITE PHARMACEUTICALS, INC.
By: /s/ Bernard Berk
-----------------------------
Name: Bernard Berk
Title: Chief Executive Officer